← Home / ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP)
Stock Analysis
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP)
ASBP
ASBP · Market data
6.36 +2.75%
52W Range Position
26%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-06-18 13:37 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 21.92. Holding above 5.88 keeps the current thesis intact.
⚖️
Fundamentals
Insufficient / Negative
Price Structure
Constructive
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
5.88
Break Above
Confirmation improves above resistance.
21.92
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below 5.88
What's Driving ASBP?
📈 Technical recovery is improving
Momentum is Neutral. Watch 21.92 for confirmation and 5.88 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 5.88
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
RSI(14)
60.0
How to read this setup
The nearest decision zone is framed by support around 4.10 and resistance near 21.98. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
ASBP · WOI overlay chart
Open Full Workspace
Business Lens
Financial pressure is elevated
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Insufficient
Profitability
Negative
Cash Flow
Pressured
Balance Sheet
Manageable
💵 Revenue
28,353
≈ Insufficient
📈 Net Income
-3.22M
↘ Negative
🧮 EPS (Basic)
-20.57
↘ Negative
ASPIRE BIOPHARMA HOLDINGS, INC.
Note: This is an algorithmic technical snapshot, not financial advice.